Our patient is a 54-year-old male presented with visual loss and loss of libido, diagnosed with macroprolactinoma, with institution of D2-agonist therapy, prolactin levels normalized but tumor continued to grow.
Gillam MP, Middler S, Freed DJ, Molitch ME. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab. 2002 Oct;87(10):4447-51.